Back to Newsroom

Conatus Pharmaceuticals Announces Late-Breaking Oral Presentation at AASLD Annual Meeting

SAN DIEGO, Nov. 16, 2015 (GLOBE NEWSWIRE) — Conatus Pharmaceuticals Inc. (NASDAQ:CNAT) announced today the delivery of a late-breaking oral presentation at The Liver Meeting®, the annual meeting of the American Association for the Study of Liver Diseases (AASLD) in San Francisco November 13-17, 2015. The presentation (#LB6), entitled “Emricasan (IDN-6556) administered orally for 28 days lowers portal pressure in patients with compensated cirrhosis and severe portal hypertension,” will be delivered in Room 3000 of the Moscone West Convention Center at 4:15 p.m. PST today by lead author Guadalupe Garcia-Tsao, M.D., a principal investigator in the trial and Professor of Medicine (Digestive Diseases) at Yale University Medical School; Chief, Digestive Diseases, VA-CT Healthcare System; and Director, Clinical and Translational Core, Yale Liver Center. The presentation visuals will be available after the live presentation in the Data section of the Conatus website at www.conatuspharma.com.

Click here to read more